HistoSonics Achieves CE Mark for Edison Histotripsy Technology
MINNEAPOLIS, Minn., July 13, 2026 HistoSonics has achieved a major international regulatory milestone after receiving CE Mark approval for...
non-invasive therapy
Advertisement
Sonire Therapeutics Launches U.S. HIFU Trial in Cancer
PALO ALTO, California, May 1, 2026 Sonire Therapeutics Inc. announced the initiation of its first U.S. clinical trial, SUNRISE-II,...
Earflo Wins FDA Clearance for Pediatric Ear Device
SAN CARLOS, CALIFORNIA, April 29, 2026 Earflo has announced the FDA clearance and U.S. market availability of its innovative...
Oculis Highlights Late-Stage Eye Pipeline at AAO 2025
October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...
Advertisement
